Free Trial

Novem Group Makes New Investment in Perrigo Company plc (NYSE:PRGO)

Perrigo logo with Medical background

Novem Group bought a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 101,167 shares of the company's stock, valued at approximately $2,601,000. Novem Group owned 0.07% of Perrigo as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Pacer Advisors Inc. grew its stake in shares of Perrigo by 2.1% in the 4th quarter. Pacer Advisors Inc. now owns 20,337 shares of the company's stock worth $523,000 after buying an additional 427 shares during the last quarter. Cedar Wealth Management LLC grew its stake in shares of Perrigo by 2.1% in the fourth quarter. Cedar Wealth Management LLC now owns 21,966 shares of the company's stock worth $565,000 after acquiring an additional 450 shares during the last quarter. Amalgamated Bank grew its stake in shares of Perrigo by 0.8% in the fourth quarter. Amalgamated Bank now owns 64,086 shares of the company's stock worth $1,648,000 after acquiring an additional 522 shares during the last quarter. Fox Run Management L.L.C. increased its holdings in shares of Perrigo by 5.1% during the fourth quarter. Fox Run Management L.L.C. now owns 11,381 shares of the company's stock valued at $293,000 after acquiring an additional 548 shares in the last quarter. Finally, Snowden Capital Advisors LLC boosted its stake in Perrigo by 3.6% in the 4th quarter. Snowden Capital Advisors LLC now owns 24,337 shares of the company's stock worth $626,000 after purchasing an additional 842 shares in the last quarter. Institutional investors own 95.91% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a research report on Saturday. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $33.00.

View Our Latest Research Report on PRGO

Perrigo Stock Performance

Shares of NYSE:PRGO traded up $0.12 during midday trading on Monday, hitting $26.52. The company had a trading volume of 1,277,471 shares, compared to its average volume of 1,520,112. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $30.93. The company has a fifty day moving average of $26.19 and a two-hundred day moving average of $26.18. The company has a market cap of $3.65 billion, a price-to-earnings ratio of -22.67 and a beta of 0.45. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.56 by $0.04. The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Perrigo's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period last year, the firm posted $0.29 earnings per share. On average, equities research analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 4.37%. The ex-dividend date of this dividend is Friday, May 30th. Perrigo's payout ratio is -88.55%.

Insider Buying and Selling at Perrigo

In related news, EVP Ronald Craig Janish sold 7,800 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.70% of the company's stock.

Perrigo Company Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines